[On experience with the antirheumatic agent Arcobutina].
D000632:Aminopyrine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D010919:Placebos; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013997:Time Factors
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D010919:Placebos; D011720:Pyrazoles; D000632:Aminopyrine
Uber Erfahrungen mit dem Antirheumatikum Arcobutina.